Charles Schwab’s Evolent Health EVH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.44M | Buy |
1,949,446
+433,231
| +29% | +$1.37M | ﹤0.01% | 2453 |
|
|
2025
Q4 | $6.06M | Buy |
1,516,215
+211,749
| +16% | +$1.18M | ﹤0.01% | 2362 |
|
|
2025
Q3 | $11M | Buy |
1,304,466
+121,650
| +10% | +$1.18M | ﹤0.01% | 2068 |
|
|
2025
Q2 | $13.3M | Buy |
1,182,816
+159,739
| +16% | +$1.47M | ﹤0.01% | 1879 |
|
|
2025
Q1 | $9.69M | Buy |
1,023,077
+104,085
| +11% | +$1.05M | ﹤0.01% | 1970 |
|
|
2024
Q4 | $10.3M | Buy |
918,992
+6,597
| +0.7% | +$116K | ﹤0.01% | 1998 |
|
|
2024
Q3 | $25.8M | Sell |
912,395
-45,742
| -5% | -$1.18M | ﹤0.01% | 1554 |
|
|
2024
Q2 | $18.3M | Buy |
958,137
+21,274
| +2% | +$543K | ﹤0.01% | 1734 |
|
|
2024
Q1 | $30.7M | Buy |
936,863
+42,591
| +5% | +$1.36M | 0.01% | 1347 |
|
|
2023
Q4 | $29.5M | Buy |
894,272
+35,276
| +4% | +$998K | 0.01% | 1345 |
|
|
2023
Q3 | $23.4M | Buy |
858,996
+107,963
| +14% | +$3M | 0.01% | 1405 |
|
|
2023
Q2 | $22.8M | Buy |
751,033
+83,517
| +13% | +$2.7M | 0.01% | 1404 |
|
|
2023
Q1 | $21.7M | Sell |
667,516
-40,906
| -6% | -$1.29M | 0.01% | 1410 |
|
|
2022
Q4 | $19.9M | Buy |
708,422
+86,798
| +14% | +$2.49M | 0.01% | 1450 |
|
|
2022
Q3 | $22.3M | Buy |
621,624
+34,312
| +6% | +$1.21M | 0.01% | 1288 |
|
|
2022
Q2 | $18M | Sell |
587,312
-678
| -0.1% | -$19.8K | 0.01% | 1482 |
|
|
2022
Q1 | $19M | Buy |
587,990
+15,177
| +3% | +$397K | 0.01% | 1590 |
|
|
2021
Q4 | $15.8M | Buy |
572,813
+25,530
| +5% | +$732K | ﹤0.01% | 1750 |
|
|
2021
Q3 | $17M | Buy |
547,283
+5,672
| +1% | +$136K | 0.01% | 1704 |
|
|
2021
Q2 | $11.4M | Buy |
541,611
+13,225
| +3% | +$265K | ﹤0.01% | 1925 |
|
|
2021
Q1 | $10.7M | Buy |
528,386
+16,994
| +3% | +$323K | ﹤0.01% | 1926 |
|
|
2020
Q4 | $8.2M | Buy |
511,392
+7,308
| +1% | +$96.6K | ﹤0.01% | 1972 |
|
|
2020
Q3 | $6.26M | Buy |
504,084
+1,734
| +0.3% | +$20.4K | ﹤0.01% | 1963 |
|
|
2020
Q2 | $3.58M | Buy |
502,350
+30,224
| +6% | +$202K | ﹤0.01% | 2187 |
|
|
2020
Q1 | $2.56M | Buy |
472,126
+12,218
| +3% | +$109K | ﹤0.01% | 2171 |
|
|
2019
Q4 | $4.16M | Buy |
459,908
+10,309
| +2% | +$83.7K | ﹤0.01% | 2116 |
|
|
2019
Q3 | $3.23M | Buy |
449,599
+21,503
| +5% | +$154K | ﹤0.01% | 2188 |
|
|
2019
Q2 | $3.4M | Buy |
428,096
+24,661
| +6% | +$292K | ﹤0.01% | 2157 |
|
|
2019
Q1 | $5.08M | Buy |
403,435
+18,563
| +5% | +$294K | ﹤0.01% | 1976 |
|
|
2018
Q4 | $7.68M | Sell |
384,872
-574
| -0.1% | -$13.3K | 0.01% | 1638 |
|
|
2018
Q3 | $10.9M | Buy |
385,446
+45,852
| +14% | +$1.09M | 0.01% | 1576 |
|
|
2018
Q2 | $7.15M | Buy |
339,594
+27,390
| +9% | +$518K | 0.01% | 1815 |
|
|
2018
Q1 | $4.45M | Buy |
312,204
+14,749
| +5% | +$211K | ﹤0.01% | 2005 |
|
|
2017
Q4 | $3.66M | Buy |
297,455
+52,696
| +22% | +$743K | ﹤0.01% | 2072 |
|
|
2017
Q3 | $4.36M | Buy |
244,759
+56,780
| +30% | +$1.17M | ﹤0.01% | 1946 |
|
|
2017
Q2 | $4.77M | Buy |
187,979
+124,799
| +198% | +$3M | ﹤0.01% | 1845 |
|
|
2017
Q1 | $1.41M | Buy |
63,180
+3,591
| +6% | +$68.9K | ﹤0.01% | 2316 |
|
|
2016
Q4 | $882K | Buy |
59,589
+3,234
| +6% | +$63.7K | ﹤0.01% | 2473 |
|
|
2016
Q3 | $1.39M | Buy |
56,355
+13,571
| +32% | +$317K | ﹤0.01% | 2296 |
|
|
2016
Q2 | $822K | Buy |
42,784
+504
| +1% | +$6.92K | ﹤0.01% | 2410 |
|
|
2016
Q1 | $447K | Buy |
42,280
+11,912
| +39% | +$123K | ﹤0.01% | 2621 |
|
|
2015
Q4 | $368K | Buy |
30,368
+16,880
| +125% | +$249K | ﹤0.01% | 2781 |
|
|
2015
Q3 | $216K | Buy |
+13,488
| New | +$263K | ﹤0.01% | 2938 |
|
Other funds holding EVH
CCM
RF
EC
VCM
RSCM
